Skye Bioscience, Inc. (SKYE)
Recent Filing Index
| Form | Filed | Qtr End | F_Period | 8K: Earnings Release |
|---|---|---|---|---|
| 10-QLatest | Q1-2026 | — | ||
| 10-KLatest | FY-2025 | 8-K (2026-03-10) · 99.1 | ||
| 10-Q | Q3-2025 | 8-K (2025-11-10) · 99.1 | ||
| 10-Q | Q2-2025 | 8-K (2025-08-07) · 99.1 | ||
| 10-Q | Q1-2025 | 8-K (2025-05-08) · 99.1 | ||
| 10-K | FY-2024 | 8-K (2025-03-20) · 99.1 | ||
| 10-Q | Q3-2024 | 8-K (2024-11-07) · 99.1 | ||
| 10-Q | Q2-2024 | — | ||
| 10-Q | Q1-2024 | — | ||
| 10-K | FY-2023 | — | ||
| 10-Q | Q3-2023 | — | ||
| 10-Q | Q2-2023 | — |
Filing Summary
| Report Name | Notes | Fiscal Period (Annual) | Fiscal Period (Quarter) |
|---|---|---|
| Cover | ||
| Audit Information | — |
|
| Statements | ||
| Consolidated Balance Sheets | ||
| Consolidated Balance Sheets (P) | ||
| Consolidated Statements of Operations | ||
| Consolidated Statements of Cash Flows | ||
| Consolidated Statements of Stockholders' Equity | ||
| Consolidated Statements of Cash Flows (P) | ||
| Consolidated Statements of Stockholders' (deficit) Equity | ||
| Consolidated Statements of Stockholders' Equity (P) | ||
| Consolidated Statements of Stockholders' (deficit) Equity (P) | ||
| Notes | ||
| Acquisition of Emerald Health Therapeutics, Inc. | — |
|
| Asset Acquisitions | ||
| Asset Acquisitions and Dispositions | ||
| Asset Dispositions | — |
|
| Commitments and Contingencies | ||
| Contingencies | — |
|
| Cybersecurity Risk Management and Strategy Disclosure | — |
|
| Debt | ||
| Fair Value Measurement | ||
| Income Taxes | — |
|
| Insider Trading Arrangements | ||
| Insider Trading Policies and Procedures | — |
|
| Licensed Intellectual Property | — |
|
| Loss Per Share of Common Stock | ||
| Nature of Operations and Business Activities | ||
| Organization, Basis of Presentation and Significant Accounting Policies | — |
|
| Other Current Assets and Liabilities | — |
|
| Pay Vs Performance Disclosure | ||
| Prepaid Expenses, Other Current Assets and Liabilities | — |
|
| Prepaid Expenses, Other Current Assets and Other Current Liabilities | — |
|
| Prepaid Expenses, Other Current Assets, Property and Equipment and Other Current Liabilities | — |
|
| Property and Equipment, Prepaid Expenses, Other Current Assets and Liabilities | ||
| Related Party Matters | ||
| Segment Reporting | ||
| Significant Contracts | — |
|
| Stock-based Compensation | ||
| Stockholders' Equity and Capitalization | ||
| Subsequent Events | ||
| Summary of Significant Accounting Policies | ||
| Warrants | ||
| Warrants and Derivative Liabilities | ||